Paul Evans

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Andy C. Rawstron, Neus Villamor, Matthias Ritgen et al. · Leukemia · 2007 · 396 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +14

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Andy C. Rawstron, Michael J. Green, Anita Kuzmicki et al. · Blood · 2002 · 334 citations

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Paul Evans, Ch Pott, Patricia J.T.A. Groenen et al. · Leukemia · 2006 · 296 citations

B-cell Malignancies, Lymphoid Neoplasia, Hematological Malignancy +7

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

J. Han van Krieken, Anton W. Langerak, Elizabeth Macintyre et al. · Leukemia · 2006 · 284 citations

Lymphoid Neoplasia, Oncology, Engineering +14

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Andy C. Rawstron, Ben Kennedy, Paul Evans et al. · Blood · 2001 · 266 citations · Full text